Table 3 Epidemiological, clinical and biochemical characteristics of 41 patients with Child-Pugh Class B cirrhosis
Variables | Patient Cohort |
|---|---|
Age [yrs] | 55 (31–75) |
Gender n (%) | |
female | 41.5% (17.0) |
male | 58.5% (24.0) |
BMI [kg/m2] | 27.2 (17.5–37.88) |
Aetiology n (%) | |
alcoholic | 16 (39%) |
cholestatic | 6 (14.6%) |
NAFLD | 4 (9.8%) |
viral | 4 (9.8%) |
others | 11 (26.8%) |
Serum albumin [g/L] | 3.39 (2.51–4.98) |
Serum bilirubin [g/dL] | 3,3 (0.15–20.62) |
INR | 1.34 (0.91–1.79) |
Platelet count [/nL] | 125 (40–377) |
Serum creatinine [mg/dL] | 1.34 (0.39–8.90) |
Serum sodium [mmol/L] | 137.4 (127–145) |
Ascites grade n (%) | |
none/mild | 24 (58.5%) |
moderate | 7 (17.1%) |
severe | 10 (24.4%) |
HE grade n (%) | |
grade 0 | 22 (53.7) |
grade I | 16 (39) |
grade II | 1 (2.4) |
grade III + IV | 2 (4.8) |
Oesophageal varices n (%) | |
yes | 32 (78%) |
no | 9 (22%) |
unknown | 0 |
Previous GI haemorrhage n (%) | 13 (31.7%) |
Child-Pugh classes n (%) | |
A | 0 (0) |
B | 41 (100%) |
C | 0 (0) |
Fibroscan stiffness [kPa] | 38.5 (20.5–59.3) |
MELD | 14.6 (8–28) |
MELD-Na | 16.2 (7–28) |
CreLiMAx | 0.93 (0.89–0.95) |
LiMAx [μg/kg/h] | 184 (44–725) |
Underwent LTx n (%) | 3 (7.3%) |
Liver-related death n (%) | 7 (17.1%) |